Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Loh

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
JACC. Cardiovascular Interventions|October 20, 2012
Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesionsJoshua P Loh, Ron Waksman
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 4, 2014
The current status of drug-coated balloons in percutaneous coronary and peripheral interventionsJoshua P Loh, Israel M Barbash, Ron Waksman
Journal of the American College of Cardiology|January 29, 2013
Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring SystemJoshua P Loh, Israel M Barbash, Ron Waksman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2014
Management of a large atrial septal occluder embolized to the left ventricular outflow tract without the use of cardiac surgeryJoshua P Loh, Lowell F Satler, Michael C Slack
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 3, 2014
Real-time, two-way interaction during ST-segment elevation myocardial infarction management improves door-to-balloon timesGabriel L Sardi, Joshua P Loh, Rebecca Torguson, et al.
Asiaintervention|December 9, 2022
Selective use of drug-eluting stents in high-risk versus bare metal stents in low-risk patients according to predefined criteria confers similar four-year long-term clinical outcomesRajiv Ananthakrishna, Joshua P Loh, Liang Shen, et al.
Clinical Cardiology|October 20, 2020
Spontaneous coronary artery dissection: clinical implications and diagnostic challenges. Overlooked and underappreciated in Asia?Ting-Ting Low, Marie Houdmont, Hui W Sim, et al.
American Heart Journal|September 1, 2014
Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentationsJoshua P Loh, Lakshmana K Pendyala, Rebecca Torguson, et al.
Journal of Interventional Cardiology|June 26, 2013
Optimal revascularization strategies for percutaneous coronary intervention of distal anastomotic lesions after coronary artery bypass surgerySalem Badr, Hironori Kitabata, Danny Dvir, et al.
The American Journal of Cardiology|April 29, 2014
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stentsJoshua P Loh, Rebecca Torguson, Lakshmana K Pendyala, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
JACC. Cardiovascular Interventions|October 20, 2012
Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesionsJoshua P Loh, Ron Waksman
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 4, 2014
The current status of drug-coated balloons in percutaneous coronary and peripheral interventionsJoshua P Loh, Israel M Barbash, Ron Waksman
Journal of the American College of Cardiology|January 29, 2013
Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring SystemJoshua P Loh, Israel M Barbash, Ron Waksman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2014
Management of a large atrial septal occluder embolized to the left ventricular outflow tract without the use of cardiac surgeryJoshua P Loh, Lowell F Satler, Michael C Slack
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 3, 2014
Real-time, two-way interaction during ST-segment elevation myocardial infarction management improves door-to-balloon timesGabriel L Sardi, Joshua P Loh, Rebecca Torguson, et al.
Asiaintervention|December 9, 2022
Selective use of drug-eluting stents in high-risk versus bare metal stents in low-risk patients according to predefined criteria confers similar four-year long-term clinical outcomesRajiv Ananthakrishna, Joshua P Loh, Liang Shen, et al.
Clinical Cardiology|October 20, 2020
Spontaneous coronary artery dissection: clinical implications and diagnostic challenges. Overlooked and underappreciated in Asia?Ting-Ting Low, Marie Houdmont, Hui W Sim, et al.
American Heart Journal|September 1, 2014
Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentationsJoshua P Loh, Lakshmana K Pendyala, Rebecca Torguson, et al.
Journal of Interventional Cardiology|June 26, 2013
Optimal revascularization strategies for percutaneous coronary intervention of distal anastomotic lesions after coronary artery bypass surgerySalem Badr, Hironori Kitabata, Danny Dvir, et al.
The American Journal of Cardiology|April 29, 2014
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stentsJoshua P Loh, Rebecca Torguson, Lakshmana K Pendyala, et al.
Pageof 6